Ratnakar Securities Limited.

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01031Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's

BSE1166.900.45 (+0.04 %)

PREV CLOSE ( ) 1166.45

OPEN PRICE ( ) 1171.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 102482

TODAY'S LOW / HIGH ( )1161.70 1192.80

52 WK LOW / HIGH ( )1025.9 1377.95

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 24-02 1984

Management Info

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email mail@drreddys.com / shares@drreddys.com

Website www.drreddys.com

Registrars Details

Bigshare Services Pvt Ltd

306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad

Listing : BSE, NSE, New York

NEWS

16Jan Dr. Reddy's Laboratories inches up on
Dr. Reddy's Laboratories is currently trading at Rs. 1187.85, up by 1.40..

16Jan Dr. Reddy's Laboratories launches Olop
Dr. Reddy's Laboratories has launched over-the-counter (OTC) Olopatadine..

06Jan Dr Reddys Laboratories informs about c
Dr Reddys Laboratories has informed that it enclosed Confirmation Certif..

06Jan Dr Reddys Laboratories informs about p
Dr Reddys Laboratories has informed that it enclosed copies of newspaper..

17Dec Dr. Reddyâ€™s Laboratories informs abo
Dr. Reddyâ€™s Laboratories has informed that it enclosed the copies of n..

Financials

in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	3873	53494
Gross Profit	5163	72359
Operating Profit	8445	83852
Net Sales	46186	231154

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Mankind Pharma (BSE) 2123.90 (0.29%)	M.Cap ( in Cr)87473.39
Procter&Gamble Healt (BSE) 5446.45 (0.09%)	M.Cap ( in Cr)9090.65
Tyche Inds (BSE) 115.00 (4.17%)	M.Cap ( in Cr)115.36
Innova Captab (BSE) 652.05 (0.44%)	M.Cap ( in Cr)3642.65
Mangalam Drugs&Org. (BSE) 51.92 (4.99%)	M.Cap ( in Cr)82.18

Shareholding Pattern

	NON-INSTITUTION	9.72%
	PROMOTERS	26.64%
	FI/BANKS/INSURANCE	14.06%
	MUTUAL FUNDS/UTI	13.87%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Nifty ...	9.38
ICICI Pru Nifty Pha...	9.38
Aditya Birla SL Nif...	7.89
Axis NIFTY Healthcare ETF	7.89
ICICI Pru Nifty Hea...	7.89
DSP Nifty Healthcare ETF	7.88

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

DR. REDDY'S LABORATORIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES